We are live on ! Find out more
CII

CR Intrinsic Investors Portfolio holdings

AUM $2.67B
1-Year Est. Return 28.43%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+28.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.89B
AUM Growth
Cap. Flow
+$2.87B
Cap. Flow %
99.28%
Top 10 Hldgs %
12.92%
Holding
330
New
330
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$51.9M
2
ZTS icon
Zoetis
ZTS
+$42.1M
3
RNR icon
RenaissanceRe
RNR
+$38.4M
4
AMZN icon
Amazon
AMZN
+$37.6M
5
SCI icon
Service Corp International
SCI
+$36.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.36%
2 Healthcare 12.18%
3 Industrials 9.7%
4 Communication Services 9.53%
5 Materials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WW
151
PUT
DELISTED
WW International
WW
$6.9M 0.24%
+150,000
New +$6.54M
PCP
152
DELISTED
PRECISION CASTPARTS CORP
PCP
$6.78M 0.23%
+30,000
New +$6.08M
META icon
153
Meta Platforms (Facebook)
META
$1.52T
$6.72M 0.23%
+270,501
New +$6.93M
ST icon
154
Sensata Technologies
ST
$6.66B
$6.72M 0.23%
+192,500
New +$6.58M
NXGN
155
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$6.55M 0.23%
+350,000
New +$6.38M
HCC
156
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
$6.37M 0.22%
+147,719
New +$6.27M
MA icon
157
Mastercard
MA
$493B
$6.32M 0.22%
+110,010
New +$6.11M
TYC
158
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$6.26M 0.22%
+181,450
New +$6.23M
JBHT icon
159
JB Hunt Transport Services
JBHT
$25B
$6.14M 0.21%
+85,000
New +$6.14M
CTRX
160
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$6.09M 0.21%
+125,000
New +$6.52M
ALXN
161
DELISTED
Alexion Pharmaceuticals
ALXN
$6.09M 0.21%
+66,001
New +$6.36M
MRSH
162
Marsh
MRSH
$91B
$5.99M 0.21%
+150,000
New +$5.87M
PRA
163
DELISTED
ProAssurance
PRA
$5.96M 0.21%
+114,277
New +$5.69M
CAG icon
164
Conagra Brands
CAG
$7.07B
$5.94M 0.21%
+218,450
New +$5.91M
CAH icon
165
Cardinal Health
CAH
$55.5B
$5.9M 0.2%
+125,000
New +$5.71M
MLCO icon
166
Melco Resorts & Entertainment
MLCO
$2.12B
$5.82M 0.2%
+260,400
New +$6.14M
OREX
167
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.58M 0.19%
+95,460
New +$5.87M
CLNY
168
DELISTED
Colony Capital, Inc.
CLNY
$5.57M 0.19%
+280,000
New +$6.1M
DWRE
169
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$5.56M 0.19%
+131,001
New +$3.97M
DF
170
DELISTED
Dean Foods Company
DF
$5.51M 0.19%
+275,000
New +$5.03M
RHI icon
171
Robert Half
RHI
$4.37B
$5.38M 0.19%
+162,010
New +$5.58M
NRF
172
DELISTED
NorthStar Realty Finance Corp.
NRF
$5.23M 0.18%
+292,819
New +$5.34M
BFAM icon
173
Bright Horizons
BFAM
$3.81B
$5.17M 0.18%
+149,000
New +$5.03M
IPXL
174
DELISTED
Impax Laboratories, Inc.
IPXL
$5.15M 0.18%
+258,000
New +$4.58M
LPNT
175
DELISTED
LifePoint Health, Inc.
LPNT
$5.13M 0.18%
+105,000
New +$5.03M

Similar funds

CR Intrinsic Investors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for CR Intrinsic Investors, which disclosed 330 positions worth $2.89B. Its ten largest holdings account for 13% of the portfolio.

Its largest position is Freeport-McMoran: 1,700,000 shares worth $46.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, followed by Healthcare and Industrials.

  • CR Intrinsic Investors's largest Q2 2013 buy was Freeport-McMoran: 1,700,000 shares worth $46.9M.
  • CR Intrinsic Investors's ten largest holdings make up 13% of its $2.89B portfolio in Q2 2013.
  • CR Intrinsic Investors disclosed 330 positions in Q2 2013, its first 13F filing on record.

Based on CR Intrinsic Investors's 13F filing for Q2 2013, filed 14 Aug 2013.